These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 7282520)

  • 1. Digoxin disposition in obesity: clinical pharmacokinetic investigation.
    Abernethy DR; Greenblatt DJ; Smith TW
    Am Heart J; 1981 Oct; 102(4):740-4. PubMed ID: 7282520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cimetidine disposition in obesity.
    Abernethy DR; Greenblatt DJ; Matlis R; Gugler R
    Am J Gastroenterol; 1984 Feb; 79(2):91-4. PubMed ID: 6364798
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Obesity effects on nitrazepam disposition.
    Abernethy DR; Greenblatt DJ; Locniskar A; Ochs HR; Harmatz JS; Shader RI
    Br J Clin Pharmacol; 1986 Nov; 22(5):551-7. PubMed ID: 3790401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Theophylline disposition in obesity.
    Gal P; Jusko WJ; Yurchak AM; Franklin BA
    Clin Pharmacol Ther; 1978 Apr; 23(4):438-44. PubMed ID: 630791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caffeine disposition in obesity.
    Abernethy DR; Todd EL; Schwartz JB
    Br J Clin Pharmacol; 1985 Jul; 20(1):61-6. PubMed ID: 4027137
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenytoin disposition in obesity. Determination of loading dose.
    Abernethy DR; Greenblatt DJ
    Arch Neurol; 1985 May; 42(5):468-71. PubMed ID: 3994563
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolongation of ifosfamide elimination half-life in obese patients due to altered drug distribution.
    Lind MJ; Margison JM; Cerny T; Thatcher N; Wilkinson PM
    Cancer Chemother Pharmacol; 1989; 25(2):139-42. PubMed ID: 2557169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carbamazepine pharmacokinetics in obese and lean subjects.
    Caraco Y; Zylber-Katz E; Berry EM; Levy M
    Ann Pharmacother; 1995 Sep; 29(9):843-7. PubMed ID: 8547729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lidocaine disposition in obesity.
    Abernethy DR; Greenblatt DJ
    Am J Cardiol; 1984 Apr; 53(8):1183-6. PubMed ID: 6702701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of obesity on apparent volume of distribution of theophylline.
    Rohrbaugh TM; Danish M; Ragni MC; Yaffe SJ
    Pediatr Pharmacol (New York); 1982; 2(1):75-83. PubMed ID: 7110759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dose-independent pharmacokinetics of digoxin in humans.
    Ochs HR; Greenblatt DJ; Bodem G; Harmatz JS
    Am Heart J; 1978 Oct; 96(4):507-11. PubMed ID: 358815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity, sex, and acetaminophen disposition.
    Abernethy DR; Divoll M; Greenblatt DJ; Ameer B
    Clin Pharmacol Ther; 1982 Jun; 31(6):783-90. PubMed ID: 7075126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of digoxin in low-birth-weight infants.
    Collins-Nakai RL; Schiff D; Ng PK
    Dev Pharmacol Ther; 1982; 5(1-2):86-97. PubMed ID: 7151640
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prolongation of drug half-life due to obesity: studies of desmethyldiazepam (clorazepate).
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Pharm Sci; 1982 Aug; 71(8):942-4. PubMed ID: 6811726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procainamide disposition in obesity.
    Christoff PB; Conti DR; Naylor C; Jusko WJ
    Drug Intell Clin Pharm; 1983; 17(7-8):516-22. PubMed ID: 6191939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Digoxin-quinidine interaction Pharmacokinetic evaluation.
    Hager WD; Fenster P; Mayersohn M; Perrier D; Graves P; Marcus FI; Goldman S
    N Engl J Med; 1979 May; 300(22):1238-41. PubMed ID: 431681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced glucuronide conjugation of drugs in obesity: studies of lorazepam, oxazepam, and acetaminophen.
    Abernethy DR; Greenblatt DJ; Divoll M; Shader RI
    J Lab Clin Med; 1983 Jun; 101(6):873-80. PubMed ID: 6133901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Doxorubicin clearance in the obese.
    Rodvold KA; Rushing DA; Tewksbury DA
    J Clin Oncol; 1988 Aug; 6(8):1321-7. PubMed ID: 3411343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacokinetics of digoxin in sheep: limitations of the use of biological half-life for interspecies extrapolation.
    Dix LP; Bai SA; Rogers RA; Anderson DL; Riviere JE
    Am J Vet Res; 1985 Feb; 46(2):470-2. PubMed ID: 3994115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the volume of distribution of digoxin reduced in patients with renal dysfunction? Determining digoxin pharmacokinetics by fluorescence polarization immunoassay.
    Cheng JW; Charland SL; Shaw LM; Kobrin S; Goldfarb S; Stanek EJ; Spinler SA
    Pharmacotherapy; 1997; 17(3):584-90. PubMed ID: 9165563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.